Sclerosing stromal tumor (SST) was first delineated as a distinct ovarian sex cord stromal tumor in 1973 by Chalvardjian and Scully. It is a benign neoplasm, distinguished from other ovarian stromal tumors by the production of collagen and a pseudolobular pattern, and it tends to occur in the second and third decades of life in diagnosed patients. We discovered two rare cases of SST in post-menopausal women which are the topic of this report. These case studies are accompanied by a brief review of the literature. 
Introduction
Sclerosing stromal tumor (SST) is a rare benign ovarian neoplasm of the sex cord stromal category first delineated as a distinct ovarian sex cord stromal tumor entity in 1973 by Chalvardjian and Scully. 1 Most patients afflicted with SST present with nonspecific symptoms related to an adnexal mass. The tumor, with rare exceptions, is hormonally inactive. Diagnosis of SST can be confirmed by postoperative pathologic examination. It is important to perform differential diagnoses of SST relative to other sex cord stromal tumors including fibroma, thecoma and lipoid cell tumors. 2 It is distinguished from other ovarian stromal tumors by the production of collagen, a pseudolobular pattern, and it tends to occur in the second and third decades of patient life. 3 Herein, we present two cases of SST occurred in postmenopausal women with brief review of literature.
Case Report were white to yellow and fibrotic in appearance (Fig. 2) .
Microscopically evaluated, the solid area showed a pseudolobular pattern alternating between hypercellular and hypocellular areas (Fig. 3A) . The cellular areas were composed of dual cell populations: collagen-producing spindle cells and rounded weak lutein cells (Fig. 3B) 
Discussion
SST of the ovary is a distinct ovarian stromal tumor subtype. 4 Ovarian SST most commonly occurs during the second to third decades of life at an average age of diagnosis of 27.5 years. More than 80% of SST cases occur in patients under 30 years of age. 5 It is rare that SST is diagnosed in postmenopausal women, however, recently it has been reported that a 80-year-old woman had SST. It is far more difficult to diagnose SST in elderly women for many reasons; the incidence is much lower in elderly women, symptoms related to menstruation cycle can be hidden due to patients' menopause, and various common conditions can cause non-specific abdominal pain in senior populations. 6 In children and adolescents, symptoms include premature menarche, menstrual irregularities, abdominal discomfort/ pain, and rarely, ascites. 6 In post-menarcheal females, SST presents with menstrual irregularities and/or an abdominal mass. In our cases, the patients presented with abdominal pain and a palpable mass. SST sizes vary from 1.5 to 20 cm in diameter. 5 In patients with SST, serum CA-125 levels have been found to be either elevated or within reference ranges. Histologically, SST is characterized by cellular heterogeneity, prominent vasculature, and a pseudolobular structure composed of both cellular and hypocellular areas. 12 The name "sclerosing stromal tumor" was proposed because the cellular portions of the tumor tend to undergo collagenous sclerosis. SST has occasionally been confused with massive ovarian edema and Krukenberg's tumor.
The distinction between SST and Krukenberg's tumor can be made using IHC staining. 4 SST is positive for desmin and smooth muscle action (SMA). Inhibin also has been shown to be positive and be a useful marker for ovarian sex cord stromal tumors. 13, 14 In addition, both the cellular and edematous areas are positive for vascular endothelial growth factor. Other stromal tumors, i.e. thecoma and fibroma, tend to occur in the fifth and sixth decades of life of afflicted patients 15 whereas almost 80 % of SSTs occur in women under 30 years of age. 13 While most cases of SST have been reported to occur in the second and third decades of life, in this report, we present two cases of SST in postmenopausal women. We expect that this report will be helpful in the differential diagnosis of future SST cases that may occur in atypical patient populations.
